Jiangsu gdk Biotechnology Co., Ltd.
SSE:688670.SS
13.52 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 80.803 | 134.591 | 318.486 | 392.272 | 589.099 | 67.151 | 0 | 0 |
| Cost of Revenue
| 30.215 | 29.864 | 50.588 | 57.179 | 73.67 | 10.495 | 21.069 | 0 |
| Gross Profit
| 50.587 | 104.727 | 267.898 | 335.094 | 515.428 | 56.657 | -21.069 | 0 |
| Gross Profit Ratio
| 0.626 | 0.778 | 0.841 | 0.854 | 0.875 | 0.844 | 0 | 0 |
| Reseach & Development Expenses
| 33.609 | 15.472 | 32.409 | 35.26 | 28.533 | 23.754 | 12.077 | 18.316 |
| General & Administrative Expenses
| 25.704 | 16.112 | 12.993 | 12.566 | 24.158 | 7.607 | 7.306 | 7.651 |
| Selling & Marketing Expenses
| 39.176 | 68.449 | 107.494 | 116.273 | 209.133 | 25.973 | 0 | 0 |
| SG&A
| 64.88 | 84.561 | 120.487 | 128.84 | 233.29 | 33.58 | 7.306 | 7.651 |
| Other Expenses
| 66.391 | 79.383 | 36.822 | 27.916 | 16.165 | 24.444 | -0.007 | 0.025 |
| Operating Expenses
| 164.88 | 179.416 | 189.719 | 192.015 | 277.989 | 81.778 | 38.775 | 44.236 |
| Operating Income
| -114.292 | -81.671 | 95.161 | 150.793 | 211.742 | -25.121 | -41.356 | -47.329 |
| Operating Income Ratio
| -1.414 | -0.607 | 0.299 | 0.384 | 0.359 | -0.374 | 0 | 0 |
| Total Other Income Expenses Net
| -1.457 | -4.903 | -0.53 | 0.034 | -0.813 | -6.125 | -0.007 | 0.025 |
| Income Before Tax
| -115.749 | -86.574 | 48.409 | 84.001 | 210.929 | -31.247 | -41.363 | -47.304 |
| Income Before Tax Ratio
| -1.432 | -0.643 | 0.152 | 0.214 | 0.358 | -0.465 | 0 | 0 |
| Income Tax Expense
| -22.247 | -15.584 | 6.865 | 1.541 | 55.949 | -12.209 | -13.35 | -14.642 |
| Net Income
| -93.503 | -70.99 | 41.544 | 82.46 | 154.979 | -19.038 | -28.013 | -32.662 |
| Net Income Ratio
| -1.157 | -0.527 | 0.13 | 0.21 | 0.263 | -0.284 | 0 | 0 |
| EPS
| -0.76 | -0.58 | 0.34 | 0.67 | 1.26 | -0.15 | -0.4 | -0.46 |
| EPS Diluted
| -0.76 | -0.58 | 0.34 | 0.67 | 1.26 | -0.15 | -0.4 | -0.65 |
| EBITDA
| -84.151 | -53.381 | 79.449 | 121.932 | 246.395 | -4.983 | -19.656 | -25.26 |
| EBITDA Ratio
| -1.041 | -0.397 | 0.249 | 0.311 | 0.418 | -0.074 | 0 | 0 |